Celgene
Investments
65
Lead Investments
17
Celgene Corporation is a pharmaceutical company that specializes in developing and commercializing innovative therapies for cancer and immune-inflammatory-related diseases. It was acquired by Bristol Myers Squibb, a global biopharmaceutical company, in 2019.
Highlights
Focus Areas
Biotechnology
Health Care
Therapeutics
Medical
Pharmaceutical
Notable Investments
